Stay updated on Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added, replacing v3.5.0. This appears to be a system update and does not change the study history data shown on the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:56:25.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    New page revision v3.5.0 was added and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:04:36.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The version history now lists a new revision v3.4.3 and removes the previous v3.4.2 from the log.
    Difference
    0.1%
    Check dated 2026-03-11T16:58:31.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Entries in the Study Status and Contacts/Locations sections were added and removed, updating the trial's status and the list of participating sites.
    Difference
    0.1%
    Check dated 2026-03-04T13:49:38.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page shows a new site revision tag v3.4.2, replacing the previous v3.4.1. This appears to be a minor platform update rather than substantive changes to the study record.
    Difference
    0.1%
    Check dated 2026-02-11T02:33:31.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0 from the page history.
    Difference
    0.1%
    Check dated 2026-02-03T23:49:05.000Z thumbnail image

Stay in the know with updates to Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.